SelectION Overview

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.43M

  • Investors
  • 7

SelectION General Information

Description

Developer of peptide therapeutics designed to assist in the treatment of autoimmune diseases and disorders. The company's therapeutics use an ion channel technology platform to discover and develop selective peptides by functionally inhibiting and eliminating disease-associated chronically activated TEM cells without compromising the protective immune response, enabling healthcare professionals to achieve effective treatments for pain management and oncology.

Contact Information

Formerly Known As
ConoGenetix, ConoGenetix biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 655 India Street
  • Suite 204
  • San Diego, CA 92101
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 655 India Street
  • Suite 204
  • San Diego, CA 92101
  • United States

SelectION Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SelectION Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 15-Sep-2025 $5.43M Completed Clinical Trials - Phase 1
7. Later Stage VC (Series B) 05-Jun-2023 Completed Clinical Trials - Phase 1
6. Later Stage VC (Series A1) 08-Apr-2021 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series A) 30-May-2019 Completed Clinical Trials - Phase 1
4. Grant 23-Jan-2013 Completed Clinical Trials - Phase 1
3. Grant 16-Jul-2012 Completed Clinical Trials - Phase 1
2. Seed Round 15-Mar-2002 Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 01-Jan-2001 Completed Clinical Trials - Phase 1
To view SelectION’s complete valuation and funding history, request access »

SelectION Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-1
Series A 16,354,270 $0.000010 8% $0.25 $0.25 1x $0.25 48.49%
To view SelectION’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SelectION Patents

SelectION Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026093602-A1 D-cys38 epimer of kv1.3 inhibitor Pending 04-Nov-2024
WO-2026093599-A1 Method for peptide oxidation and folding Pending 04-Nov-2024
WO-2026093598-A1 Peptide with low content of d-cys38 epimer Pending 04-Nov-2024
AU-2024408749-A1 Peptide for treating atopic dermatitis Pending 21-Dec-2023
EP-4827891-A1 Peptide for treating atopic dermatitis Pending 21-Dec-2023 A61K38/16
To view SelectION’s complete patent history, request access »

SelectION Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SelectION Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Source Ventures Venture Capital Minority
Mey Capital Matrix Venture Capital Minority
SDL Ventures Venture Capital Minority
Bay Area Biosciences Association Corporation
Bundesministerium für Bildung und Forschung Government
You’re viewing 5 of 7 investors. Get the full list »

SelectION FAQs

  • Where is SelectION headquartered?

    SelectION is headquartered in San Diego, CA.

  • What is the size of SelectION?

    SelectION has 3 total employees.

  • What industry is SelectION in?

    SelectION’s primary industry is Drug Discovery.

  • Is SelectION a private or public company?

    SelectION is a Private company.

  • What is SelectION’s current revenue?

    The current revenue for SelectION is .

  • How much funding has SelectION raised over time?

    SelectION has raised $19.6M.

  • Who are SelectION’s investors?

    Global Source Ventures, Mey Capital Matrix, SDL Ventures, Bay Area Biosciences Association, and Bundesministerium für Bildung und Forschung are 5 of 7 investors who have invested in SelectION.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process